Latest On Applied Therapeutics, Inc (APLT):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-25 17:49 EST | News | Applied Therapeutics' govorestat gets orphan drug tag in EU for muscle disorder | N/A |  |
| 2023-05-12 20:29 EST | News | Applied Therapeutics files for $300M mixed shelf offering | N/A | |
| 2023-05-11 16:38 EST | News | Applied Therapeutics GAAP EPS of -$0.18 beats by $0.25 | N/A | |
| 2023-04-24 15:29 EST | News | Applied Therapeutics up 12% on $30M offering | N/A | |
| 2023-03-23 15:11 EST | News | Applied Therapeutics GAAP EPS of -$2.18 beats by $0.44 | N/A | |
| 2023-02-16 10:29 EST | News | Applied Therapeutics rises ~10% as AT-007 shows efficacy in phase 3 trial for muscle disorder | N/A | |
| 2023-01-04 16:19 EST | News | Applied Therapeutics adds 19% on partnership with Advanz Pharma for lead asset | N/A | |
| 2022-11-09 20:15 EST | News | Applied Therapeutics GAAP EPS of -$0.40 beats by $0.12 | N/A | |
| 2022-08-12 14:52 EST | News | Applied Therapeutics GAAP EPS of -$0.96 misses by $0.40 | N/A | |
| 2022-06-23 08:22 EST | News | Applied Therapeutics launches stock offering | N/A | |
| 2022-06-23 08:22 EST | News | Applied therapeutics stock sinks on pricing $30M equity offering | N/A | |
| 2022-06-03 16:37 EST | News | Applied Therapeutics stock rises on EMA orphan drug status for metabolic disorder drug AT-007 | N/A | |
| 2022-05-12 12:44 EST | News | Applied Therapeutics GAAP EPS of -$0.88 | N/A | |
| 2022-03-18 11:47 EST | News | Applied Therapeutics (APLT) Investor Presentation - Slideshow | N/A | |
| 2022-03-10 12:07 EST | News | Applied Therapeutics GAAP EPS of -$4.12 beats by $0.31 | N/A | |
| 2022-01-19 08:51 EST | News | Applied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's Stock | N/A | |
| 2022-01-04 09:07 EST | News | Applied Therapeutics plummeted 30% after delay in NDA filing | N/A | |
| 2022-01-03 16:23 EST | News | Applied Therapeutics to delay submission of marketing application for galactosemia therapy | N/A | |
| 2021-11-24 14:05 EST | News | Warning: APLT is at high risk of performing badly | N/A | |
| 2021-11-12 16:45 EST | News | Applied Therapeutics EPS beats by $0.01 | N/A | |
| 2021-10-25 12:52 EST | News | Applied Therapeutics highlights biomarker data from pilot trial of AT-007 | N/A | |
| 2021-10-19 05:32 EST | News | Applied Therapeutics drug benefits kids in rare metabolic disorder, plans Q4 NDA filing | N/A | |
| 2021-09-09 20:17 EST | News | Applied Therapeutics delays NDA for rare pediatric metabolic disease candidate to Q4 | N/A | |
| 2021-08-30 07:40 EST | News | Applied Therapeutics cut to sell at Goldman Sachs citing regulatory and financing risks | N/A | |
| 2021-08-12 12:19 EST | News | Applied Therapeutics EPS beats by $0.09 | N/A | |
| 2021-07-20 19:06 EST | News | Applied Therapeutics trades higher on FDA Fast Track designation for rare metabolic disorder | N/A | |
| 2021-07-20 18:59 EST | News | Applied Therapeutics added to Russell Microcap Index | N/A | |
| 2021-03-19 04:11 EST | Earnings Estimate | An EPS average of -$4.14 is estimated for the 2022 year. | Sell | |
| 2021-03-19 04:11 EST | Earnings Estimate | An EPS average of -$1.08 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-18 13:52 EST | News | Applied Therapeutics EPS beats by $0.26 | N/A | |
| 2021-02-12 14:29 EST | News | Applied Therapeutics secures $69M via equity offering | N/A | |
| 2021-02-11 02:54 EST | News | Applied Therapeutics plans 3M share public offering | N/A | |
| 2021-02-04 07:07 EST | Analyst Rating | The Analyst Target Price has decreased from $53 to $49.83. | Neutral | |
| 2021-02-02 21:47 EST | News | Applied Therapeutics to resume galactosemia study for AT-007 | N/A | |
| 2021-01-20 00:03 EST | News | Applied Therapeutics And The Murky World Of Biopharma Development | N/A | |
| 2020-12-16 01:58 EST | News | Larimar, Avadel, Applied Therapeutics will added to Nasdaq Biotechnology Index | N/A | |
| 2020-12-13 03:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-20 11:08 EST | Analyst Rating | The Analyst Target Price has decreased from $53.5 to $53. | Neutral | |
| 2020-11-18 11:08 EST | Analyst Rating | The Analyst Target Price has decreased from $56.83 to $53.5. | Neutral | |
| 2020-11-17 03:08 EST | Analyst Rating | The Analyst Target Price has decreased from $60.5 to $56.83. | Neutral | |
| 2020-11-15 19:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-15 11:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 11:12 EST | Earnings Estimate | An EPS average of -$1.14 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-12 16:59 EST | News | Applied Therapeutics EPS misses by $0.21 | N/A | |
| 2020-11-01 17:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 12:09 EST | Analyst Rating | The Analyst Target Price has increased from $60.17 to $60.5. | Buy | |
| 2020-10-30 08:48 EST | Insider Trade | Riccardo Perfetti has directly disposed of 465 shares and currently holds 0 shares. | Sell | |
| 2020-10-30 08:48 EST | Insider Trade | Riccardo Perfetti has directly acquired 465 shares and currently holds 465 shares. | Buy | |
| 2020-10-30 08:48 EST | Insider Trade | Riccardo Perfetti has directly disposed of 465 shares and currently holds 0 shares. | Sell | |
| 2020-10-30 08:48 EST | Insider Trade | Riccardo Perfetti has directly acquired 465 shares and currently holds 465 shares. | Buy | |
About Applied Therapeutics, Inc (APLT):
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that is in phase I/II for the treatment of galactosemia; AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy; and AT-003 that is in phase I clinical trial for the treatment diabetic retinopathy. The company's preclinical stage products include AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
General
- Name Applied Therapeutics, Inc
- Symbol APLT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 22
- Fiscal Year EndDecember
- IPO Date2019-05-14
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Web URLhttp://www.appliedtherapeutics.com
View More
Valuation
- Price/Book (Most Recent Quarter) 4.96
View More
Financials
- Most Recent Quarter 2020-09-30
- Current Year EPS Estimate -$4.47
- Next Year EPS Estimate -$4.14
- Next Quarter EPS Estimate -$1.08
- Return on Assets -68%
- Return on Equity -132%
- Earnings Per Share -$3.69
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 519.91 million
- Analyst Target Price $49.83
- Book Value Per Share $4.58
View More
Share Statistics
- Shares Outstanding 25.94 million
- Shares Float 12.11 million
- % Held by Insiders 2388%
- % Held by Institutions 71.47%
- Shares Short 1.23 million
- Shares Short Prior Month 1.62 million
- Short Ratio 7.17
- Short % of Float 7%
- Short % of Shares Outstanding 5%
View More
Technicals
- 52 Week High $51.99
- 52 Week Low $13.58
- 50 Day Moving Average 22.08
- 200 Day Moving Average 21.59
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Applied Therapeutics, Inc (APLT) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Applied Therapeutics, Inc (APLT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | -$1.06 | -$1.25 | 15.2% | |
| 2020-09-30 | 2020-11-12 | $N/A | -$1.33 | -$0.89 | -48.99% |
| 2020-06-30 | 2020-08-11 | $N/A | -$1.27 | -$0.68 | -85.75% |
| 2020-03-31 | 2020-05-11 | $N/A | -$0.59 | -$0.84 | 29.48% |
| 2019-12-31 | 2020-03-13 | $N/A | -$1.57 | -$0.64 | -145.73% |
| 2019-09-30 | 2019-11-13 | $N/A | -$0.63 | -$0.44 | -42.63% |
| 2019-06-30 | 2019-08-12 | $N/A | -$0.60 | -$0.43 | -39.89% |
| 2019-03-31 | 2019-06-21 | $N/A | -$0.67 | -$0.39 | -71.79% |
Applied Therapeutics, Inc (APLT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Applied Therapeutics, Inc (APLT) Chart:
Applied Therapeutics, Inc (APLT) News:
Below you will find a list of latest news for Applied Therapeutics, Inc (APLT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Applied Therapeutics, Inc (APLT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 170.85 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0.2 | CALL | 155 | 115 | 86.88 | FALSE | -0.05 | -0.2 |
| 2024-05-17 | 7.5 | 0.01 | CALL | 0 | 1122 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0.07 | CALL | 0 | 1255 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0.1 | CALL | 0 | 673 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.07 | PUT | 0 | 362 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0.8 | PUT | 0 | 874 | 104.62 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 2.35 | PUT | 0 | 66 | 146.67 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 0 | PUT | 0 | 0 | 202.47 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 290.81 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 180.38 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0.48 | CALL | 4 | 0 | 94.19 | FALSE | 0.48 | 0 |
| 2024-06-21 | 7.5 | 0.05 | CALL | 101 | 1 | 83.03 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 93.22 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 104.95 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0 | PUT | 0 | 0 | 113.22 | TRUE | 0 | 0 |
| 2024-07-19 | 2.5 | 2.22 | CALL | 0 | 390 | 121.59 | TRUE | 0 | 0 |
| 2024-07-19 | 5 | 0.64 | CALL | 5 | 2549 | 95.12 | FALSE | -0.06 | -0.09 |
| 2024-07-19 | 7.5 | 0.2 | CALL | 1 | 2759 | 98.47 | FALSE | -0.05 | -0.2 |
| 2024-07-19 | 10 | 0.2 | CALL | 0 | 4198 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 12.5 | 0.35 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 15 | 0.36 | CALL | 0 | 138 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 17.5 | 0.15 | CALL | 0 | 607 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 2.5 | 0.15 | PUT | 0 | 293 | 112.24 | FALSE | 0 | 0 |
| 2024-07-19 | 5 | 0.7 | PUT | 0 | 630 | 89.49 | TRUE | 0 | 0 |
| 2024-07-19 | 7.5 | 3 | PUT | 0 | 43 | 102.7 | TRUE | 0 | 0 |
| 2024-07-19 | 10 | 0 | PUT | 0 | 0 | 115.79 | TRUE | 0 | 0 |
| 2024-07-19 | 12.5 | 0 | PUT | 0 | 0 | 208.13 | TRUE | 0 | 0 |
| 2024-07-19 | 15 | 0 | PUT | 0 | 0 | 181.53 | TRUE | 0 | 0 |
| 2024-07-19 | 17.5 | 0 | PUT | 0 | 0 | 174.1 | TRUE | 0 | 0 |
| 2024-10-18 | 2.5 | 2.5 | CALL | 0 | 17 | 133.84 | TRUE | 0 | 0 |
| 2024-10-18 | 5 | 1.2 | CALL | 0 | 798 | 114.61 | FALSE | 0 | 0 |
| 2024-10-18 | 7.5 | 0.75 | CALL | 3 | 842 | 117.55 | FALSE | 0.05 | 0.07 |
| 2024-10-18 | 10 | 0.48 | CALL | 0 | 1365 | 111.32 | FALSE | 0 | 0 |
| 2024-10-18 | 12.5 | 1.2 | CALL | 0 | 100 | 114.38 | FALSE | 0 | 0 |
| 2024-10-18 | 15 | 0.5 | CALL | 0 | 93 | 113.31 | FALSE | 0 | 0 |
| 2024-10-18 | 17.5 | 0.7 | CALL | 0 | 173 | 114.43 | FALSE | 0 | 0 |
| 2024-10-18 | 2.5 | 0.46 | PUT | 0 | 1572 | 121.99 | FALSE | 0 | 0 |
| 2024-10-18 | 5 | 1.65 | PUT | 0 | 113 | 97.75 | TRUE | 0 | 0 |
| 2024-10-18 | 7.5 | 3.5 | PUT | 0 | 8 | 113.99 | TRUE | 0 | 0 |
| 2024-10-18 | 10 | 0 | PUT | 0 | 0 | 108.33 | TRUE | 0 | 0 |
| 2024-10-18 | 12.5 | 0 | PUT | 0 | 0 | 143.32 | TRUE | 0 | 0 |
| 2024-10-18 | 15 | 0 | PUT | 0 | 0 | 108.28 | TRUE | 0 | 0 |
| 2024-10-18 | 17.5 | 0 | PUT | 0 | 0 | 120.14 | TRUE | 0 | 0 |
| 2025-01-17 | 2.5 | 2.62 | CALL | 0 | 501 | 146.26 | TRUE | 0 | 0 |
| 2025-01-17 | 5 | 1.5 | CALL | 51 | 33 | 159.7 | FALSE | 1.5 | 0 |
| 2025-01-17 | 7.5 | 1 | CALL | 0 | 12 | 107.74 | FALSE | 0 | 0 |
| 2025-01-17 | 10 | 1.25 | CALL | 0 | 20 | 113.32 | FALSE | 0 | 0 |
| 2025-01-17 | 12.5 | 1.34 | CALL | 0 | 7 | 118.65 | FALSE | 0 | 0 |
| 2025-01-17 | 2.5 | 0.65 | PUT | 0 | 29 | 137.08 | FALSE | 0 | 0 |
| 2025-01-17 | 5 | 1.95 | PUT | 0 | 1 | 161.44 | TRUE | 0 | 0 |
| 2025-01-17 | 7.5 | 0 | PUT | 0 | 0 | 160.04 | TRUE | 0 | 0 |
| 2025-01-17 | 10 | 0 | PUT | 0 | 0 | 160.37 | TRUE | 0 | 0 |
| 2025-01-17 | 12.5 | 0 | PUT | 0 | 0 | 161.42 | TRUE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | CALL | 0 | 0 | 127.57 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 2.7 | CALL | 0 | 6 | 117.48 | FALSE | 0 | 0 |
| 2026-01-16 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 12.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | PUT | 0 | 0 | 125.05 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0 | PUT | 0 | 0 | 108.03 | TRUE | 0 | 0 |
| 2026-01-16 | 7.5 | 0 | PUT | 0 | 0 | 107.19 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 0 | PUT | 0 | 0 | 105.93 | TRUE | 0 | 0 |
| 2026-01-16 | 12.5 | 0 | PUT | 0 | 0 | 112.5 | TRUE | 0 | 0 |
Latest APLT Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:53 PM EST | 86 | $1.265 |
| Jun 13, 2022 7:55 PM EST | 10 | $1.265 |
| Jun 13, 2022 7:58 PM EST | 10 | $1.265 |
| Jun 13, 2022 7:58 PM EST | 50 | $1.265 |
| Jun 13, 2022 7:58 PM EST | 43 | $1.265 |
Applied Therapeutics, Inc (APLT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2019-02-15 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1697532/000000000019002467/0000000000-19-002467-index.htm |
| 2019-03-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1697532/000000000019005376/0000000000-19-005376-index.htm |
| 2019-12-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1697532/000000000019016551/0000000000-19-016551-index.htm |
| 2020-01-17 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1697532/000000000020000456/0000000000-20-000456-index.htm |
| 2020-06-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1697532/000000000020005144/0000000000-20-005144-index.htm |
| 2020-08-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1697532/000031506620001680/0000315066-20-001680-index.htm |
| 2019-01-25 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1697532/000091205719000026/0000912057-19-000026-index.htm |
| 2019-03-08 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1697532/000091205719000080/0000912057-19-000080-index.htm |
| 2019-03-27 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1697532/000091205719000125/0000912057-19-000125-index.htm |
| 2020-01-10 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1697532/000091205720000011/0000912057-20-000011-index.htm |
| 2017-02-08 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1697532/000091476017000017/0000914760-17-000017-index.htm |
| 2019-11-21 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1697532/000095017219000131/0000950172-19-000131-index.htm |
| 2019-05-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000103544319000140/0001035443-19-000140-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000103544319000142/0001035443-19-000142-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000103544320000079/0001035443-20-000079-index.htm |
| 2019-04-12 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1697532/000104746919002204/0001047469-19-002204-index.htm |
| 2019-04-24 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1697532/000104746919002548/0001047469-19-002548-index.htm |
| 2019-04-29 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1697532/000104746919002659/0001047469-19-002659-index.htm |
| 2019-05-14 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1697532/000104746919003094/0001047469-19-003094-index.htm |
| 2019-12-13 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1697532/000104746919006843/0001047469-19-006843-index.htm |
| 2019-12-19 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1697532/000104746919006897/0001047469-19-006897-index.htm |
| 2019-12-23 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1697532/000104746919006940/0001047469-19-006940-index.htm |
| 2020-01-21 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1697532/000104746920000339/0001047469-20-000339-index.htm |
| 2020-01-23 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1697532/000104746920000444/0001047469-20-000444-index.htm |
| 2020-01-24 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1697532/000104746920000481/0001047469-20-000481-index.htm |
| 2020-03-16 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1697532/000104746920001490/0001047469-20-001490-index.htm |
| 2020-04-21 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1697532/000104746920002463/0001047469-20-002463-index.htm |
| 2019-04-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1697532/000110465919023277/0001104659-19-023277-index.htm |
| 2019-05-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1697532/000110465919027139/0001104659-19-027139-index.htm |
| 2019-05-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1697532/000110465919027140/0001104659-19-027140-index.htm |
| 2019-05-06 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1697532/000110465919027141/0001104659-19-027141-index.htm |
| 2019-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919030034/0001104659-19-030034-index.htm |
| 2019-05-20 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1697532/000110465919030598/0001104659-19-030598-index.htm |
| 2019-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919031803/0001104659-19-031803-index.htm |
| 2019-05-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1697532/000110465919032050/0001104659-19-032050-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919032065/0001104659-19-032065-index.htm |
| 2019-05-29 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1697532/000110465919032185/0001104659-19-032185-index.htm |
| 2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919034283/0001104659-19-034283-index.htm |
| 2019-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919034409/0001104659-19-034409-index.htm |
| 2019-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919036821/0001104659-19-036821-index.htm |
| 2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919037098/0001104659-19-037098-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919044149/0001104659-19-044149-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919044692/0001104659-19-044692-index.htm |
| 2019-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919045179/0001104659-19-045179-index.htm |
| 2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919048585/0001104659-19-048585-index.htm |
| 2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919048732/0001104659-19-048732-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465919062212/0001104659-19-062212-index.htm |
| 2019-12-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1697532/000110465919073728/0001104659-19-073728-index.htm |
| 2020-01-21 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1697532/000110465920005582/0001104659-20-005582-index.htm |
| 2020-01-21 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1697532/000110465920005586/0001104659-20-005586-index.htm |
| 2020-01-22 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1697532/000110465920005844/0001104659-20-005844-index.htm |
| 2020-01-23 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1697532/000110465920006417/0001104659-20-006417-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1697532/000110465920021996/0001104659-20-021996-index.htm |
| 2020-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465920021999/0001104659-20-021999-index.htm |
| 2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465920032753/0001104659-20-032753-index.htm |
| 2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465920041936/0001104659-20-041936-index.htm |
| 2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465920049003/0001104659-20-049003-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465920059092/0001104659-20-059092-index.htm |
| 2020-05-11 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1697532/000110465920059123/0001104659-20-059123-index.htm |
| 2020-05-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465920065642/0001104659-20-065642-index.htm |
| 2020-06-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1697532/000110465920068461/0001104659-20-068461-index.htm |
| 2020-06-05 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1697532/000110465920069963/0001104659-20-069963-index.htm |
| 2020-06-05 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1697532/000110465920069971/0001104659-20-069971-index.htm |
| 2020-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465920070364/0001104659-20-070364-index.htm |
| 2020-06-12 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1697532/000110465920072958/0001104659-20-072958-index.htm |
| 2020-06-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1697532/000110465920072971/0001104659-20-072971-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465920092998/0001104659-20-092998-index.htm |
| 2020-08-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1697532/000110465920095670/0001104659-20-095670-index.htm |
| 2020-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000110465920095852/0001104659-20-095852-index.htm |
| 2020-04-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1697532/000114036120009524/0001140361-20-009524-index.htm |
| 2020-04-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1697532/000114036120009526/0001140361-20-009526-index.htm |
| 2018-02-20 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1697532/000114420418009827/0001144204-18-009827-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1697532/000117266120000918/0001172661-20-000918-index.htm |
| 2019-05-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119029499/0001209191-19-029499-index.htm |
| 2019-05-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119029500/0001209191-19-029500-index.htm |
| 2019-05-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119029501/0001209191-19-029501-index.htm |
| 2019-05-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119029502/0001209191-19-029502-index.htm |
| 2019-05-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119029503/0001209191-19-029503-index.htm |
| 2019-05-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119029504/0001209191-19-029504-index.htm |
| 2019-05-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119029505/0001209191-19-029505-index.htm |
| 2019-05-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119029506/0001209191-19-029506-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119030074/0001209191-19-030074-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119030078/0001209191-19-030078-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119030080/0001209191-19-030080-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119030081/0001209191-19-030081-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119030083/0001209191-19-030083-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119030085/0001209191-19-030085-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119030088/0001209191-19-030088-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119031447/0001209191-19-031447-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119031448/0001209191-19-031448-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119031450/0001209191-19-031450-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119031452/0001209191-19-031452-index.htm |
| 2019-05-29 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119033218/0001209191-19-033218-index.htm |
| 2019-05-29 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119033219/0001209191-19-033219-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119034754/0001209191-19-034754-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119061180/0001209191-19-061180-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919119061182/0001209191-19-061182-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120005367/0001209191-20-005367-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120005368/0001209191-20-005368-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120007706/0001209191-20-007706-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120009468/0001209191-20-009468-index.htm |
| 2020-03-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120016701/0001209191-20-016701-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120018230/0001209191-20-018230-index.htm |
| 2020-04-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120023447/0001209191-20-023447-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-05-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120032167/0001209191-20-032167-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120033310/0001209191-20-033310-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034791/0001209191-20-034791-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034792/0001209191-20-034792-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034793/0001209191-20-034793-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034794/0001209191-20-034794-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034795/0001209191-20-034795-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120038359/0001209191-20-038359-index.htm |
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-08-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120048318/0001209191-20-048318-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm |
| 2020-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1697532/000120919120056497/0001209191-20-056497-index.htm |
| 2019-05-07 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1697532/000135445719000258/0001354457-19-000258-index.htm |
| 2019-03-08 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1697532/000141057819000127/0001410578-19-000127-index.htm |
| 2019-03-27 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1697532/000141057819000157/0001410578-19-000157-index.htm |
| 2019-06-21 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1697532/000155837019005822/0001558370-19-005822-index.htm |
| 2019-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1697532/000155837019007973/0001558370-19-007973-index.htm |
| 2019-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1697532/000155837019010886/0001558370-19-010886-index.htm |
| 2019-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1697532/000155837019010931/0001558370-19-010931-index.htm |
| 2020-03-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1697532/000155837020002630/0001558370-20-002630-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1697532/000155837020006110/0001558370-20-006110-index.htm |
| 2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1697532/000155837020010266/0001558370-20-010266-index.htm |
| 2018-11-19 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1697532/000169753218000002/0001697532-18-000002-index.htm |
| 2019-05-13 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1697532/999999999519001102/9999999995-19-001102-index.htm |
| 2019-12-20 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1697532/999999999519002895/9999999995-19-002895-index.htm |
| 2020-01-23 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1697532/999999999520000151/9999999995-20-000151-index.htm |
| 2020-03-23 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1697532/999999999520000607/9999999995-20-000607-index.htm |
| 2020-06-09 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1697532/999999999520001375/9999999995-20-001375-index.htm |
| 2020-06-15 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1697532/999999999520001430/9999999995-20-001430-index.htm |
Applied Therapeutics, Inc (APLT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Applied Therapeutics, Inc (APLT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2388%Institutional Ownership: 7147%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-10-27 | Riccardo Perfetti | Chief Medical Officer | Sell | 465.00 | 21.20 | 9,858.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm |
| 2020-10-28 | Riccardo Perfetti | Chief Medical Officer | Sell | 465.00 | 18.49 | 8,597.85 | 0.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm |
| 2020-10-29 | Riccardo Perfetti | Chief Medical Officer | Sell | 465.00 | 17.27 | 8,030.55 | 0.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm |
| 2020-05-29 | Leslie D. Funtleyder | Director | Sell | 8,495.00 | 45.08 | 382,954.60 | 17,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm |
| 2020-06-04 | Leslie D. Funtleyder | Director | Sell | 1,482.00 | 44.17 | 65,459.94 | 17,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm |
| 2020-06-10 | Leslie D. Funtleyder | Director | Sell | 2,563.00 | 42.83 | 109,773.29 | 17,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm |
| 2020-06-18 | Leslie D. Funtleyder | Director | Sell | 11.00 | 45.90 | 504.90 | 17,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120038359/0001209191-20-038359-index.htm |
| 2020-06-25 | Leslie D. Funtleyder | Director | Sell | 100.00 | 38.28 | 3,828.00 | 17,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-08-24 | Leslie D. Funtleyder | Director | Sell | 6,461.00 | 24.18 | 156,226.98 | 17,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120048318/0001209191-20-048318-index.htm |
| 2020-10-02 | Leslie D. Funtleyder | Director | Sell | 5,976.00 | 20.07 | 119,938.32 | 17,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm |
| 2020-06-18 | Leslie D. Funtleyder | Director | Sell | 7,487.00 | 45.32 | 339,310.84 | 17,159.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120038359/0001209191-20-038359-index.htm |
| 2020-06-25 | Leslie D. Funtleyder | Director | Sell | 517.00 | 37.52 | 19,397.84 | 17,248.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-06-25 | Leslie D. Funtleyder | Director | Sell | 200.00 | 36.12 | 7,224.00 | 17,765.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-06-24 | Leslie D. Funtleyder | Director | Sell | 400.00 | 40.92 | 16,368.00 | 17,965.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-06-24 | Leslie D. Funtleyder | Director | Sell | 3,811.00 | 40.41 | 154,002.51 | 18,365.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-06-03 | Leslie D. Funtleyder | Director | Sell | 1,032.00 | 44.03 | 45,438.96 | 18,630.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm |
| 2020-06-02 | Leslie D. Funtleyder | Director | Sell | 12,486.00 | 45.21 | 564,492.06 | 19,662.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm |
| 2020-06-10 | Leslie D. Funtleyder | Director | Sell | 2,622.00 | 41.80 | 109,599.60 | 19,711.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm |
| 2020-06-24 | Leslie D. Funtleyder | Director | Sell | 3,572.00 | 39.20 | 140,022.40 | 22,176.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-06-09 | Leslie D. Funtleyder | Director | Sell | 1,500.00 | 44.87 | 67,305.00 | 22,333.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm |
| 2020-10-01 | Leslie D. Funtleyder | Director | Sell | 1,353.00 | 20.75 | 28,074.75 | 23,124.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm |
| 2020-08-24 | Leslie D. Funtleyder | Director | Sell | 13,539.00 | 23.42 | 317,083.38 | 23,609.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120048318/0001209191-20-048318-index.htm |
| 2020-06-09 | Leslie D. Funtleyder | Director | Sell | 2,000.00 | 42.82 | 85,640.00 | 23,833.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm |
| 2020-10-01 | Leslie D. Funtleyder | Director | Sell | 22,671.00 | 20.03 | 454,100.13 | 24,477.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm |
| 2020-06-17 | Leslie D. Funtleyder | Director | Sell | 4,100.00 | 44.15 | 181,015.00 | 24,646.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm |
| 2020-05-29 | Leslie D. Funtleyder | Director | Sell | 7,120.00 | 44.27 | 315,202.40 | 25,643.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm |
| 2020-06-23 | Leslie D. Funtleyder | Director | Sell | 1,340.00 | 47.40 | 63,516.00 | 25,748.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-06-08 | Leslie D. Funtleyder | Director | Sell | 8,315.00 | 44.77 | 372,262.55 | 25,833.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm |
| 2020-06-23 | Leslie D. Funtleyder | Director | Sell | 160.00 | 46.45 | 7,432.00 | 27,088.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-06-23 | Leslie D. Funtleyder | Director | Sell | 1,809.00 | 45.35 | 82,038.15 | 27,248.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-06-16 | Leslie D. Funtleyder | Director | Sell | 100.00 | 45.18 | 4,518.00 | 28,746.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm |
| 2020-06-16 | Leslie D. Funtleyder | Director | Sell | 5,302.00 | 44.37 | 235,249.74 | 28,846.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm |
| 2020-06-23 | Leslie D. Funtleyder | Director | Sell | 3,462.00 | 44.54 | 154,197.48 | 29,057.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-06-02 | Leslie D. Funtleyder | Director | Buy | 15,000.00 | 4.70 | 70,500.00 | 32,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm |
| 2020-06-23 | Leslie D. Funtleyder | Director | Sell | 4,629.00 | 43.32 | 200,528.28 | 32,519.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm |
| 2020-05-28 | Leslie D. Funtleyder | Director | Sell | 2,838.00 | 48.27 | 136,990.26 | 32,763.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm |
| 2020-06-08 | Leslie D. Funtleyder | Director | Buy | 17,000.00 | 4.70 | 79,900.00 | 34,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm |
| 2020-06-15 | Leslie D. Funtleyder | Director | Buy | 17,000.00 | 4.70 | 79,900.00 | 34,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm |
| 2020-05-28 | Leslie D. Funtleyder | Director | Buy | 18,453.00 | 0.04 | 738.12 | 35,601.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm |
| 2019-05-16 | Shoshana Shendelman | President and CEO | Buy | 125,000.00 | 10.00 | 1,250,000.00 | 3,605,662.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919119031452/0001209191-19-031452-index.htm |
| 2020-03-09 | Adam Hansard | Chief Commercial Officer | Buy | 36,464.00 | 36,464.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120018230/0001209191-20-018230-index.htm | ||
| 2020-05-15 | JOEL S MARCUS | Director | Sell | 100.00 | 43.69 | 4,369.00 | 365,360.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-05-15 | JOEL S MARCUS | Director | Sell | 5,723.00 | 43.20 | 247,233.60 | 365,460.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-05-14 | JOEL S MARCUS | Director | Sell | 9,177.00 | 43.18 | 396,262.86 | 371,183.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-06-22 | Leslie D. Funtleyder | Director | Buy | 20,000.00 | 4.70 | 94,000.00 | 37,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120038359/0001209191-20-038359-index.htm |
| 2020-08-21 | Leslie D. Funtleyder | Director | Sell | 20,000.00 | 4.70 | 94,000.00 | 37,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120048318/0001209191-20-048318-index.htm |
| 2020-02-06 | Teena Lerner | Director | Buy | 18,453.00 | 1.00 | 18,453.00 | 37,623.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120007706/0001209191-20-007706-index.htm |
| 2020-05-13 | JOEL S MARCUS | Director | Sell | 2,017.00 | 49.66 | 100,164.22 | 380,360.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-05-13 | JOEL S MARCUS | Director | Sell | 2,202.00 | 48.77 | 107,391.54 | 382,377.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-05-13 | JOEL S MARCUS | Director | Sell | 1,600.00 | 47.88 | 76,608.00 | 384,579.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-05-13 | JOEL S MARCUS | Director | Sell | 2,012.00 | 46.61 | 93,779.32 | 386,179.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-05-13 | JOEL S MARCUS | Director | Sell | 500.00 | 45.29 | 22,645.00 | 388,191.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-05-13 | JOEL S MARCUS | Director | Sell | 5,905.00 | 44.46 | 262,536.30 | 388,691.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2020-05-13 | JOEL S MARCUS | Director | Sell | 10,764.00 | 43.60 | 469,310.40 | 394,596.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm |
| 2019-05-16 | JOEL S MARCUS | Director | Buy | 150,000.00 | 10.00 | 1,500,000.00 | 404,860.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919119031450/0001209191-19-031450-index.htm |
| 2020-01-28 | JOEL S MARCUS | Director | Buy | 500.00 | 45.50 | 22,750.00 | 405,360.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120005368/0001209191-20-005368-index.htm |
| 2020-10-27 | Riccardo Perfetti | Chief Medical Officer | Buy | 465.00 | 1.44 | 669.60 | 465.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm |
| 2020-10-28 | Riccardo Perfetti | Chief Medical Officer | Buy | 465.00 | 1.44 | 669.60 | 465.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm |
| 2020-10-29 | Riccardo Perfetti | Chief Medical Officer | Buy | 465.00 | 1.44 | 669.60 | 465.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm |
| 2020-10-01 | Leslie D. Funtleyder | Director | Sell | 30,000.00 | 4.70 | 141,000.00 | 47,148.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm |
| 2020-02-06 | Teena Lerner | Director | Buy | 11,970.00 | 4.70 | 56,259.00 | 49,593.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120007706/0001209191-20-007706-index.htm |
| 2020-05-28 | Shoshana Shendelman | President and CEO | Sell | 125,000.00 | 42.70 | 5,337,500.00 | 554,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120033310/0001209191-20-033310-index.htm |
| 2020-07-07 | Shoshana Shendelman | President and CEO | Sell | 13,005.00 | 32.25 | 419,411.25 | 554,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-08 | Shoshana Shendelman | President and CEO | Sell | 2,111.00 | 32.98 | 69,620.78 | 554,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-09 | Shoshana Shendelman | President and CEO | Sell | 4,064.00 | 31.64 | 128,584.96 | 554,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-20 | Shoshana Shendelman | President and CEO | Sell | 300.00 | 28.64 | 8,592.00 | 554,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-21 | Shoshana Shendelman | President and CEO | Sell | 100.00 | 28.24 | 2,824.00 | 554,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-22 | Shoshana Shendelman | President and CEO | Sell | 2,949.00 | 26.51 | 78,177.99 | 554,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-21 | Shoshana Shendelman | President and CEO | Sell | 7,300.00 | 27.42 | 200,166.00 | 554,385.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-20 | Shoshana Shendelman | President and CEO | Sell | 2,600.00 | 27.88 | 72,488.00 | 554,585.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-08 | Shoshana Shendelman | President and CEO | Sell | 12,889.00 | 32.21 | 415,154.69 | 556,396.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-20 | Shoshana Shendelman | President and CEO | Sell | 12,100.00 | 27.19 | 328,999.00 | 557,185.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-22 | Shoshana Shendelman | President and CEO | Sell | 12,051.00 | 25.45 | 306,697.95 | 557,235.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-09 | Shoshana Shendelman | President and CEO | Sell | 10,936.00 | 30.90 | 337,922.40 | 558,349.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-21 | Shoshana Shendelman | President and CEO | Sell | 7,600.00 | 26.69 | 202,844.00 | 561,685.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-07 | Shoshana Shendelman | President and CEO | Sell | 1,995.00 | 31.63 | 63,101.85 | 567,290.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-07 | Shoshana Shendelman | President and CEO | Buy | 15,000.00 | 1.44 | 21,600.00 | 569,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-08 | Shoshana Shendelman | President and CEO | Buy | 15,000.00 | 1.44 | 21,600.00 | 569,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-09 | Shoshana Shendelman | President and CEO | Buy | 15,000.00 | 1.44 | 21,600.00 | 569,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm |
| 2020-07-20 | Shoshana Shendelman | President and CEO | Buy | 15,000.00 | 1.44 | 21,600.00 | 569,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-21 | Shoshana Shendelman | President and CEO | Buy | 15,000.00 | 1.44 | 21,600.00 | 569,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-07-22 | Shoshana Shendelman | President and CEO | Buy | 15,000.00 | 1.44 | 21,600.00 | 569,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm |
| 2020-05-28 | Shoshana Shendelman | President and CEO | Buy | 27,624.00 | 1.00 | 27,624.00 | 581,909.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120033310/0001209191-20-033310-index.htm |
| 2020-06-04 | Charles Silberstein | Chief Financial Officer | Buy | 61,000.00 | 61,000.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120034794/0001209191-20-034794-index.htm | ||
| 2020-01-28 | Stacy J. Kanter | Director | Buy | 6,500.00 | 45.50 | 295,750.00 | 6,500.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120005367/0001209191-20-005367-index.htm |
| 2020-05-28 | Shoshana Shendelman | President and CEO | Buy | 97,376.00 | 1.44 | 140,221.44 | 679,285.00 | https://www.sec.gov/Archives/edgar/data/1697532/000120919120033310/0001209191-20-033310-index.htm |
| 2019-05-16 | ALEXANDRIA REAL ESTATE EQUITIES INC | 10% Share Holder | Buy | 975,000.00 | 10.00 | 9,750,000.00 | 975,000.00 | https://www.sec.gov/Archives/edgar/data/1697532/000103544319000142/0001035443-19-000142-index.htm |